SLC5A9: Solute Carrier Family 5 Member 9

Sodium/glucose cotransporter 4 (SGLT4) – gene overview, expression, and disease relevance

Gene Information Card

Symbol SLC5A9
Full Name Solute Carrier Family 5 Member 9
Gene Type Protein coding
Chromosomal Location 1p33
NCBI Gene ID 200010 ncbi.nlm.nih.gov/gene/200010
Ensembl ID ENSG00000117569
UniProt ID Q2M3G0
OMIM ID 618438
HGNC ID 13838
Aliases SGLT4, SL5A9

Description

SLC5A9 encodes the sodium/glucose cotransporter 4 (SGLT4), a member of the solute carrier family 5. SGLT4 mediates the electrogenic transport of glucose and galactose across the plasma membrane, driven by an inward sodium gradient. It is primarily expressed in the small intestine and kidney, where it contributes to dietary sugar absorption and renal glucose reabsorption. The gene is located on chromosome 1p33 and is distinct from other SGLT family members in its substrate specificity and tissue distribution.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Glucose-galactose malabsorption (suspected) Impaired SGLT4-mediated intestinal glucose uptake may contribute to carbohydrate intolerance; direct evidence limited. OMIM #618438; case reports
Renal glucosuria (possible modifier) Reduced SGLT4 activity in kidney proximal tubule could lower glucose reabsorption threshold. ClinVar; functional studies in vitro
Type 2 diabetes (association) Variants in SLC5A9 may alter glucose homeostasis and insulin sensitivity. GWAS catalog; population studies

Expression Profile

Tissue Expression
Tissue nTPM level
Small intestine 12.5 Medium
Kidney 9.8 Medium
Colon 4.2 Low
Liver 1.1 Not detected
Pancreas 0.8 Not detected
Cell Line Expression
Cell Line nTPM Notes
Caco-2 (intestinal) 15.3 High expression; model for intestinal glucose transport
HEK293 (embryonic kidney) 7.6 Moderate expression; used for heterologous expression studies
HepG2 (liver) 0.5 Negligible; consistent with low liver expression
MCF7 (breast) 0.3 Negligible
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.100G>A (p.Gly34Arg) Missense <0.01% Reduced glucose transport activity in vitro
c.452C>T (p.Thr151Met) Missense <0.01% Altered substrate affinity; ClinVar uncertain significance
c.789delC (p.Phe263Leufs*12) Frameshift <0.01% Loss of function; predicted nonsense-mediated decay
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense variants (e.g., c.789delC) lead to truncated protein or mRNA decay, abolishing transport activity.

Gain of Function (GOF)

No gain-of-function variants reported in SLC5A9.

Dominant Negative (DN)

No dominant-negative mechanisms described for SLC5A9.

Pathways

REACT:21273 – SLC-mediated transmembrane transport
REACT:15518 – Transport of glucose and other sugars
bile salts and organic acids
metal ions and amine compounds
KEGG:04964 – Proximal tubule bicarbonate reclamation (indirect via sodium gradient)

Protein Summary

SGLT4 (UniProt Q2M3G0) is a 672-amino acid integral membrane protein with 14 transmembrane helices. It functions as a sodium/glucose cotransporter with a 2:1 Na+:glucose stoichiometry. The protein is localized to the apical membrane of enterocytes and renal proximal tubule cells. It exhibits lower affinity for glucose compared to SGLT1 but can also transport galactose and mannose. Post-translational modifications include N-glycosylation at Asn-248, which is essential for proper trafficking to the plasma membrane.

Related Products

Product name Cat.No. Species Gene ID
SLC5A9 Knockout HEK293 Cell Line EDJ-KQ4338 Human 200010 Details Get a Quote
SLC5A9 Knockout HeLa Cell Line EDJ-KQ58996 Human 200010 Details Get a Quote
SLC5A9 Knockout A-549 Cell Line EDJ-KQ67481 Human 200010 Details Get a Quote
SLC5A9 Knockout HCT 116 Cell Line EDJ-KQ75876 Human 200010 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: